Argenx
ARGX
#622
Rank
โ‚น2.698 T
Marketcap
โ‚น45,130
Share price
-0.01%
Change (1 day)
2.87%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น2.698 Trillion

As of September 2024 Argenx has a market cap of โ‚น2.698 Trillion. This makes Argenx the world's 622th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024โ‚น2.698 T43.65%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.55%
2021โ‚น1.370 T33.87%
2020โ‚น1.023 T109.1%
2019โ‚น489.60 B100.75%
2018โ‚น243.88 B90.51%
2017โ‚น128.01 B
2014โ‚น9.20 B

End of Day market cap according to different sources

On Sep 15th, 2024 the market cap of Argenx was reported to be:

โ‚น2.698 Trillion
by Yahoo Finance info icon info icon
โ‚น2.698 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.671 Trillion
by Nasdaq info icon info icon